Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
46 | 3 | VIROLOGY//HIV 1//AIDS RESEARCH AND HUMAN RETROVIRUSES | 102919 |
96 | 2 | AIDS RESEARCH AND HUMAN RETROVIRUSES//HIV 1//INFECTIOUS DISEASES | 26037 |
1282 | 1 | REVERSE TRANSCRIPTASE//HIV DRUG ISTANCE PROGRAM//K65R | 2755 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | REVERSE TRANSCRIPTASE | authKW | 695612 | 11% | 21% | 295 |
2 | HIV DRUG ISTANCE PROGRAM | address | 297136 | 4% | 21% | 123 |
3 | K65R | authKW | 195173 | 1% | 74% | 23 |
4 | RNASE H | authKW | 171655 | 2% | 24% | 62 |
5 | HIV 1 REVERSE TRANSCRIPTASE | authKW | 143711 | 2% | 26% | 49 |
6 | MOL INTERACT GRP | address | 106458 | 0% | 85% | 11 |
7 | M184V | authKW | 92039 | 0% | 62% | 13 |
8 | RT BIOCHEM SECT | address | 88729 | 1% | 52% | 15 |
9 | ISTANCE MECH | address | 81404 | 0% | 65% | 11 |
10 | ANTIVIRAL THERAPY | journal | 80992 | 4% | 6% | 117 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Virology | 57276 | 35% | 1% | 952 |
2 | Infectious Diseases | 22119 | 27% | 0% | 742 |
3 | Biochemistry & Molecular Biology | 3619 | 32% | 0% | 889 |
4 | Microbiology | 3308 | 16% | 0% | 428 |
5 | Immunology | 3110 | 17% | 0% | 478 |
6 | Pharmacology & Pharmacy | 2255 | 19% | 0% | 513 |
7 | Biochemical Research Methods | 288 | 4% | 0% | 120 |
8 | Chemistry, Medicinal | 166 | 3% | 0% | 85 |
9 | Mathematical & Computational Biology | 164 | 2% | 0% | 48 |
10 | Biotechnology & Applied Microbiology | 145 | 5% | 0% | 127 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | HIV DRUG ISTANCE PROGRAM | 297136 | 4% | 21% | 123 |
2 | MOL INTERACT GRP | 106458 | 0% | 85% | 11 |
3 | RT BIOCHEM SECT | 88729 | 1% | 52% | 15 |
4 | ISTANCE MECH | 81404 | 0% | 65% | 11 |
5 | REVERSE TRANSCRIPTASE BIOCHEM SECT | 60997 | 0% | 67% | 8 |
6 | HIV DRUG ISTANCE PROGRAMNIH | 57190 | 0% | 100% | 5 |
7 | AIDS | 53111 | 6% | 3% | 154 |
8 | INT CLIN VIROL | 51462 | 0% | 50% | 9 |
9 | CHRISTOPHER BOND LIFE SCI | 47129 | 0% | 32% | 13 |
10 | HLTH CARE LIFE SCI GRP | 45752 | 0% | 100% | 4 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | ANTIVIRAL THERAPY | 80992 | 4% | 6% | 117 |
2 | AIDS | 20210 | 5% | 1% | 125 |
3 | AIDS RESEARCH AND HUMAN RETROVIRUSES | 14314 | 3% | 2% | 83 |
4 | JOURNAL OF VIROLOGY | 14077 | 8% | 1% | 224 |
5 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 11849 | 6% | 1% | 160 |
6 | JOURNAL OF HUMAN VIROLOGY | 5825 | 0% | 7% | 7 |
7 | JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 5570 | 2% | 1% | 47 |
8 | ANTIVIRAL RESEARCH | 5268 | 1% | 1% | 41 |
9 | AIDS REVIEWS | 4887 | 0% | 4% | 11 |
10 | HIV CLINICAL TRIALS | 4873 | 1% | 3% | 15 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | REVERSE TRANSCRIPTASE | 695612 | 11% | 21% | 295 | Search REVERSE+TRANSCRIPTASE | Search REVERSE+TRANSCRIPTASE |
2 | K65R | 195173 | 1% | 74% | 23 | Search K65R | Search K65R |
3 | RNASE H | 171655 | 2% | 24% | 62 | Search RNASE+H | Search RNASE+H |
4 | HIV 1 REVERSE TRANSCRIPTASE | 143711 | 2% | 26% | 49 | Search HIV+1+REVERSE+TRANSCRIPTASE | Search HIV+1+REVERSE+TRANSCRIPTASE |
5 | M184V | 92039 | 0% | 62% | 13 | Search M184V | Search M184V |
6 | HIV 1 | 79265 | 9% | 3% | 245 | Search HIV+1 | Search HIV+1 |
7 | RIBONUCLEASE H | 67403 | 1% | 24% | 25 | Search RIBONUCLEASE+H | Search RIBONUCLEASE+H |
8 | HYPERSUSCEPTIBILITY | 67274 | 0% | 59% | 10 | Search HYPERSUSCEPTIBILITY | Search HYPERSUSCEPTIBILITY |
9 | CONNECTION DOMAIN | 58822 | 0% | 86% | 6 | Search CONNECTION+DOMAIN | Search CONNECTION+DOMAIN |
10 | VIRTUAL PHENOTYPE | 58822 | 0% | 86% | 6 | Search VIRTUAL+PHENOTYPE | Search VIRTUAL+PHENOTYPE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |